Miguel A. Pujana
Girona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 66 publications
Aneuploidy selects for the acquisition of driver genes in breast cancer.
Journal: Nature
Published: August 20, 2024
Harnessing STING Signaling and Natural Killer Cells Overcomes PARP Inhibitor Resistance in Homologous Recombination-Deficient Breast Cancer.
Journal: Cancer research
Published: July 23, 2024
Fatty acid synthase (FASN) is a tumor-cell-intrinsic metabolic checkpoint restricting T-cell immunity.
Journal: Cell death discovery
Published: July 04, 2024
Cancer genetic counseling in Chile: Addressing barriers, confronting challenges, and seizing opportunities in an underserved Latin American Community.
Journal: Genetics in medicine open
Published: January 26, 2024
Biological basis of extensive pleiotropy between blood traits and cancer risk.
Journal: Genome medicine
Published: August 11, 2023
Identification of differential biological activity and synergy between the PARP inhibitor rucaparib and its major metabolite.
Journal: Cell chemical biology
Published: November 21, 2022
A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.
Journal: Molecular cancer therapeutics
Published: November 23, 2021
Ubiquitin ligase RNF8 suppresses Notch signaling to regulate mammary development and tumorigenesis.
Journal: The Journal of clinical investigation
Published: July 01, 2021
Pathogenic BRCA1 variants disrupt PLK1-regulation of mitotic spindle orientation.
Journal: Nature communications
Published: June 15, 2021
Modification of BRCA1-associated breast cancer risk by HMMR overexpression.
Journal: Nature communications
Published: May 20, 2021
Last Updated: 09/26/2026